Health Canada
Symbol of the Government of Canada
Consumer Product Safety

Incident Report

Subform I: General Information

1. Report Type.

New incident report

Incident Report Number: 2010-0572

2. Registrant Information.

Registrant Reference Number: Prosar 1-21221272

Registrant Name (Full Legal Name no abbreviations): Syngenta Crop Protection Canada, Inc.

Address: 140 Research Lane, Research Park

City: Guelph

Prov / State: Ontario

Country: Canada

Postal Code: N1G4Z3

3. Select the appropriate subform(s) for the incident.

Domestic Animal

4. Date registrant was first informed of the incident.

04-JAN-10

5. Location of incident.

Country: UNITED STATES

Prov / State: KENTUCKY

6. Date incident was first observed.

Unknown

Product Description

7. a) Provide the active ingredient and, if available, the registration number and product name (include all tank mixes). If the product is not registered provide a submission number.

Active(s)

PMRA Registration No.       PMRA Submission No.       EPA Registration No.

Product Name: Warrior (non-specific)

  • Active Ingredient(s)
    • LAMBDA-CYHALOTHRIN
      • Unknown

7. b) Type of formulation.

Liquid

Application Information

8. Product was applied?

Yes

9. Application Rate.

Unknown

10. Site pesticide was applied to (select all that apply).

Site: Agricultural-Outdoor/Agricole-extérieur

Préciser le type: Unknown

11. Provide any additional information regarding application (how it was applied, amount applied, the size of the area treated etc).

The product was applied to foliage via airplane approximately 3 months prior to the report (approximately 10/2009).

To be determined by Registrant

12. In your opinion, was the product used according to the label instructions?

Unknown

Subform III: Domestic Animal Incident Report

1. Source of Report

Medical Professional

2. Type of animal affected

Horse / Cheval

3. Breed

Unknown breed

4. Number of animals affected

1

5. Sex

Unknown

6. Age (provide a range if necessary )

Unknown

7. Weight (provide a range if necessary )

Unknown

8. Route(s) of exposure

Unknown

9. What was the length of exposure?

Unknown / Inconnu

10. Time between exposure and onset of symptoms

Unknown / Inconnu

11. List all symptoms

System

  • Gastrointestinal System
    • Symptom - Other
    • Specify - Colic
  • General
    • Symptom - Death

12. How long did the symptoms last?

Persisted until death

13. Was medical treatment provided? Provide details in question 17.

Unknown

14. a) Was the animal hospitalized?

Unknown

14. b) How long was the animal hospitalized?

15. Outcome of the incident

Died

16. How was the animal exposed?

Other / Autre

specify Potential contact with treated area

17. Provide any additional details about the incident

(eg. description of the frequency and severity of the symptoms

1-21221272: A reporter (veterinarian) called on 01/04/2010 to report the possible exposure of 4 horses to an insecticide containing the active ingredient Lambda-cyhalothrin. According to the reporter, foliage was sprayed with the product via airplane about 3 months prior to the report (approximately 10/2009). The horses potentially had inhalation and dermal exposure, and may also have eaten treated vegetation. Two months prior to the report (11/2009), Horse #1 (1st Subform III) developed acute colic and died. The other 3 horses (2nd Subform III) have had poor appetites and chronic intermittent colic. All 3 horses have blood work results that appear consistent with a viral infection. Blood work abnormalities include lymphocytosis, monocytosis, and neutropenia. The reporter was advised that the products contain the active ingredient in concentrations ranging from 11% to 22%. These products are typically diluted prior to application. Inhalation and dermal exposure to the products may result in irritation. Paraesthesia is possible following dermal exposure. Inhalation may lead to more pronounced signs in an animal with underlying respiratory issues such as COPD or heaves. Signs of irritation would be expected to develop immediately following exposure. Ingestion of significant amounts of concentrated product may result in neurologic signs such as tremors and seizures soon after exposure. Hematologic abnormalities are not expected following product exposure of any kind, and a recommendation was made to consider other causes for the horses' signs. No further information was obtained.


To be determined by Registrant

18. Severity classification (if there is more than 1 possible classification

Death

19. Provide supplemental information here

The symptoms were not consistent with exposure to Lambda-Cyhalothrin

Subform III: Domestic Animal Incident Report

1. Source of Report

Medical Professional

2. Type of animal affected

Horse / Cheval

3. Breed

Unknown breed

4. Number of animals affected

3

5. Sex

Unknown

6. Age (provide a range if necessary )

Unknown

7. Weight (provide a range if necessary )

Unknown

8. Route(s) of exposure

Unknown

9. What was the length of exposure?

Unknown / Inconnu

10. Time between exposure and onset of symptoms

Unknown / Inconnu

11. List all symptoms

System

  • Gastrointestinal System
    • Symptom - Loss of appetite
    • Symptom - Other
    • Specify - Chronic intermittent colic
  • Blood
    • Symptom - Leukocytosis
    • Specify - Lymphocytosis
    • Symptom - Leukocytosis
    • Specify - Monocytosis
    • Symptom - Leukocytosis
    • Specify - Neutropenia

12. How long did the symptoms last?

Unknown / Inconnu

13. Was medical treatment provided? Provide details in question 17.

Unknown

14. a) Was the animal hospitalized?

Unknown

14. b) How long was the animal hospitalized?

15. Outcome of the incident

Unknown/Inconnu

16. How was the animal exposed?

Other / Autre

specify Possible contact with treated area

17. Provide any additional details about the incident

(eg. description of the frequency and severity of the symptoms

1-21221272: A reporter (veterinarian) called on 01/04/2010 to report the possible exposure of 4 horses to an insecticide containing the active ingredient Lambda-cyhalothrin. According to the reporter, foliage was sprayed with the product via airplane about 3 months prior to the report (approximately 10/2009). The horses potentially had inhalation and dermal exposure, and may also have eaten treated vegetation. Two months prior to the report (11/2009), Horse #1 (1st Subform III) developed acute colic and died. The other 3 horses (2nd Subform III) have had poor appetites and chronic intermittent colic. All 3 horses have blood work results that appear consistent with a viral infection. Blood work abnormalities include lymphocytosis, monocytosis, and neutropenia. The reporter was advised that the products contain the active ingredient in concentrations ranging from 11% to 22%. These products are typically diluted prior to application. Inhalation and dermal exposure to the products may result in irritation. Paraesthesia is possible following dermal exposure. Inhalation may lead to more pronounced signs in an animal with underlying respiratory issues such as COPD or heaves. Signs of irritation would be expected to develop immediately following exposure. Ingestion of significant amounts of concentrated product may result in neurologic signs such as tremors and seizures soon after exposure. Hematologic abnormalities are not expected following product exposure of any kind, and a recommendation was made to consider other causes for the horses' signs. No further information was obtained.


To be determined by Registrant

18. Severity classification (if there is more than 1 possible classification

Moderate

19. Provide supplemental information here